HIVE Digital Technologies Ltd. operates as a technology company focused on building and running data centers powered by renewable energy. Its core business involves Bitcoin mining and the sale of digital currencies, alongside performance computing hosting for blockchain networks. The company maintains facilities in locations including Canada, Paraguay, Sweden, and Bermuda, emphasizing sustainable energy sources. This positioning in the cryptocurrency mining and emerging high-performance computing sectors exposes the stock to Bitcoin price fluctuations and growing demand for AI-adjacent infrastructure, directly influencing recent price movements through operational scaling and revenue expansion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, HIVE stock increased approximately 28%, reflecting a generally upward trend with periods of volatility tied to cryptocurrency market swings. The movement appeared trend-driven, supported by positive sector momentum rather than purely range-bound trading.
Over the past quarter, the stock posted a larger gain of roughly 80%, consistent with a sustained recovery phase. This period showed stronger cumulative upward momentum amid improving macroeconomic conditions for digital assets and company-level capacity additions.
The primary catalyst was the broader rally in Bitcoin and digital assets, which boosted mining revenues and investor appetite for crypto-related equities. HIVE reported record fiscal 2026 results, including a 158% revenue increase and a four-fold rise in operational hashrate, underscoring successful expansion. The company highlighted its pivot toward AI and high-performance computing using existing green-energy infrastructure, attracting attention from growth-oriented investors. While a recent quarterly earnings release noted a net loss and a revenue figure below some analyst expectations, the overall revenue surge and Bitcoin production growth (2,885 BTC mined for the year, up 104%) helped offset negative reactions and sustain the upward price trajectory.
Over the quarter, sustained Bitcoin price appreciation and HIVE's aggressive capacity expansion formed the dominant narrative. The company achieved significant hashrate growth through acquisitions and energization of new facilities, outpacing network difficulty increases. Macroeconomic factors, including favorable conditions for risk assets and institutional interest in cryptocurrency infrastructure, amplified gains. HIVE's strategic positioning to repurpose mining facilities for AI workloads added a longer-term growth angle, encouraging sustained buying interest despite typical sector volatility. Institutional flows and positive sentiment around green mining operations contributed to the stronger cumulative advance compared to the shorter-term period.
As part of my ongoing analysis, I frequently turn to AI Trading Bots and the AI Trend Prediction Engine to gauge how stocks like HIVE might behave under different market scenarios. These resources help put price action into context alongside broader sector trends without replacing traditional fundamental review.
Investors should monitor upcoming quarterly earnings releases for updates on Bitcoin production volumes, revenue from mining operations, and progress on AI/high-performance computing initiatives. Key factors include ongoing changes in Bitcoin prices and network difficulty, regulatory developments affecting cryptocurrency mining, and macroeconomic conditions such as interest rates and risk-asset sentiment. Strategic moves like facility expansions, energy cost management, or new partnerships in data center hosting could also influence sentiment. Potential risks involve Bitcoin price corrections or increased competition in the mining sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HIVE advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 190 cases where HIVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HIVE moved out of overbought territory on June 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where HIVE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on June 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HIVE broke above its upper Bollinger Band on May 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.905) is normal, around the industry mean (3.924). P/E Ratio (9.174) is within average values for comparable stocks, (47.485). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.770). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. P/S Ratio (2.854) is also within normal values, averaging (32.042).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers